Barely Significant
← all excerpts

Diverse Lenabasum pathway activation in dermatomyositis patients' blood.

Sci Rep · 2025 · PMC12086228 · PMID 40383862

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)
With no receptor inhibitions, moDCs showed a trend towards a significant decrease in IFNβ production when treated with lenabasum [20.7% (20.6–25) to 10.2% (8.57–10.9); p = 0.06 ] (Fig. 3 c).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.